IDP 001
Alternative Names: IDP-001Latest Information Update: 07 Jul 2025
At a glance
- Originator InduPro
- Class Antineoplastics; Auristatins; Bispecific antibodies; Drug conjugates; Immunoconjugates; Immunotherapies; Recombinant fusion proteins
- Mechanism of Action Apoptosis stimulants; Mitosis inhibitors; Tubulin inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 25 Apr 2025 Preclinical trials in Solid tumours in USA (SC)
- 25 Apr 2025 Pharmacodynamics data from preclinical trials in Solid tumours presented at the 116th Annual Meeting of the American Association for Cancer Research (AACR-2025)
- 25 Apr 2025 Pharmacodynamics, pharmacokinetics and safety data from preclinical trials in Solid tumours presented at the 116th Annual Meeting of the American Association for Cancer Research (AACR-2025)